Vista Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Sell
5,540
-32
-0.6% -$11.9K 0.64% 49
2026
Q1
$1.63M Buy
5,572
+103
+2% +$33.9K 0.54% 59
2025
Q4
$1.92M Sell
5,469
-60
-1% -$20.3K 0.63% 49
2025
Q3
$1.79M Buy
5,529
+856
+18% +$266K 0.62% 50
2025
Q2
$1.82M Buy
4,673
+28
+0.6% +$11.3K 0.67% 47
2025
Q1
$2.02M Sell
4,645
-44
-0.9% -$17.7K 0.79% 38
2024
Q4
$1.73M Buy
4,689
+607
+15% +$254K 0.66% 50
2024
Q3
$2.12M Buy
4,082
+3
+0.1% +$1.6K 0.8% 37
2024
Q2
$2.21M Buy
4,079
+33
+0.8% +$17.4K 0.9% 34
2024
Q1
$2.1M Buy
4,046
+14
+0.3% +$6.96K 0.85% 34
2023
Q4
$1.9M Buy
4,032
+134
+3% +$62K 0.88% 35
2023
Q3
$1.7M Buy
3,898
+5
+0.1% +$2.27K 0.89% 34
2023
Q2
$1.73M Sell
3,893
-45
-1% -$20.8K 0.88% 35
2023
Q1
$1.81M Sell
3,938
-8
-0.2% -$3.81K 0.96% 31
2022
Q4
$2.02M Sell
3,946
-113
-3% -$57.4K 1.16% 23
2022
Q3
$1.84M Sell
4,059
-31
-0.8% -$14.8K 1.14% 22
2022
Q2
$1.97M Sell
4,090
-111
-3% -$54.9K 1.19% 21
2022
Q1
$2.06M Sell
4,201
-142
-3% -$64.9K 1.13% 22
2021
Q4
$2.01M Sell
4,343
-56
-1% -$23.6K 1.09% 24
2021
Q3
$1.64M Sell
4,399
-59
-1% -$22.4K 0.96% 31
2021
Q2
$1.7M Sell
4,458
-88
-2% -$33.6K 1% 29
2021
Q1
$1.63M Sell
4,546
-58
-1% -$18.7K 1.02% 29
2020
Q4
$1.48M Sell
4,604
-568
-11% -$174K 0.99% 33
2020
Q3
$1.39M Buy
5,172
+8
+0.2% +$2.15K 1.06% 32
2020
Q2
$1.36M Sell
5,164
-67
-1% -$17.9K 1.17% 30
2020
Q1
$1.19M Sell
5,231
-42
-0.8% -$11.4K 1.21% 25
2019
Q4
$1.59M Sell
5,273
-134
-2% -$36.9K 1.2% 24
2019
Q3
$1.3M Sell
5,407
-119
-2% -$32.6K 1.07% 31
2019
Q2
$1.56M Sell
5,526
-114
-2% -$31.1K 1.32% 24
2019
Q1
$1.62M Sell
5,640
-194
-3% -$56.1K 1.42% 23
2018
Q4
$1.53M Sell
5,834
-194
-3% -$53.3K 1.58% 15
2018
Q3
$1.65M Sell
6,028
-160
-3% -$41.5K 1.46% 13
2018
Q2
$1.47M Buy
6,188
+20
+0.3% +$4.63K 1.44% 15
2018
Q1
$1.35M Sell
6,168
-54
-0.9% -$12.7K 1.42% 18
2017
Q4
$1.4M Buy
+6,222
New +$1.33M 1.46% 18

Other funds holding ELV

Vista Investment Management's ELV Position: Q2 2026 in Review

Vista Investment Management reduced its Elevance Health (ELV) stake by 0.57% in Q2 2026, selling an estimated $11.9K and leaving 5,540 shares worth $2.14M. The position accounts for 0.64% of the portfolio, ranked #49.

Vista Investment Management first reported a position in ELV in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.21M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vista Investment Management held 5,540 shares of Elevance Health worth $2.14M as of Q2 2026.
  • Vista Investment Management sold 32 Elevance Health shares in Q2 2026, an estimated $11.9K.
  • Elevance Health made up 0.64% of Vista Investment Management's portfolio in Q2 2026, its #49 holding.
  • Vista Investment Management first reported a position in Elevance Health in Q4 2017 and has held it in 35 quarters since.
  • Vista Investment Management's Elevance Health position peaked at $2.21M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vista Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.